Cargando…

Pancreatic Resections in Renal Failure Patients: Is It Worth the Risk?

Background. Chronic kidney disease affects 20 million US patients, with nearly 600,000 on dialysis. Long-term survival is limited and the risk of complex pancreatic surgery in this group is questionable. Previous studies are limited to case reports and small case series and a large database may help...

Descripción completa

Detalles Bibliográficos
Autores principales:	Norman, K. S., Domingo, S. R., Wong, L. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941119/ https://www.ncbi.nlm.nih.gov/pubmed/24672144 http://dx.doi.org/10.1155/2014/938251

Ejemplares similares

Portal vein resection in advanced pancreatic adenocarcinoma: is it worth the risk?
por: Marsoner, Katharina, et al.
Publicado: (2016)

Laparoscopic Partial Nephrectomy: Is It Worth Still Performing the Retroperitoneal Route?
por: Ouzaid, Idir, et al.
Publicado: (2012)

Pancreatic Resections for Advanced M1-Pancreatic Carcinoma: The Value of Synchronous Metastasectomy
por: Seelig, S. K., et al.
Publicado: (2010)

An Evaluation of Neoadjuvant Chemoradiotherapy for Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Jiang, Hui, et al.
Publicado: (2013)

Worth it or not? Primary tumor resection for stage IV pancreatic cancer patients: A SEER‐based analysis of 15,836 cases
por: Fu, Ningzhen, et al.
Publicado: (2021)

Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study
por: Blackstock, A W, et al.
Publicado: (2006)

Worsening Renal Function in Patients Hospitalized with Acute Heart Failure: Risk Factors and Prognostic Significances
por: Verdiani, Valerio, et al.
Publicado: (2010)

Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II study
por: Bernhardt, S L, et al.
Publicado: (2006)

Impact of Cardiovascular Organ Damage on Cortical Renal Perfusion in Patients with Chronic Renal Failure
por: Lubas, Arkadiusz, et al.
Publicado: (2013)

A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer
por: Ueno, H, et al.
Publicado: (2009)

Mesenteric-Portal Vein Resection during Pancreatectomy for Pancreatic Cancer
por: Beltrame, Valentina, et al.
Publicado: (2015)

Carboxypeptidase G(2) rescue in patients with methotrexate intoxication and renal failure
por: Buchen, S, et al.
Publicado: (2005)

Preliminary Results of Hyperthermic Intraperitoneal Intraoperative Chemotherapy as an Adjuvant in Resectable Pancreatic Cancer
por: Tentes, Antonios-Apostolos K., et al.
Publicado: (2012)

Acute Tubular Necrosis and Renal Failure in Patients with Glomerular Disease
por: Tavares, Maria Brandão, et al.
Publicado: (2012)

IVC Measurements in Critically Ill Patients with Acute Renal Failure
por: Jambeih, Rami, et al.
Publicado: (2017)

Locally Advanced Pancreatic Head Cancer: Margin-Positive Resection or Bypass?
por: Wellner, Ulrich Friedrich, et al.
Publicado: (2012)

Renal Function in Relation to Cardiac (123)I-MIBG Scintigraphy in Patients with Chronic Heart Failure
por: Verschure, Derk O., et al.
Publicado: (2012)

Any heart failure treatments associated with worsening renal function in patients admitted due to acute heart failure?
por: Limkunakul, Chutatip, et al.
Publicado: (2021)

Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer
por: Kaira, K, et al.
Publicado: (2012)

Should Steroid Therapy Be Necessarily Needed for Autoimmune Pancreatitis Patients with Lesion Resected due to Misdiagnosed or Suspected Malignancy?
por: Wu, Wenchuan, et al.
Publicado: (2014)

Safety and efficacy of the combination of erlotinib and sirolimus for the treatment of metastatic renal cell carcinoma after failure of sunitinib or sorafenib
por: Flaig, T W, et al.
Publicado: (2010)

Variation in Annual Volume at a University Hospital Does Not Predict Mortality for Pancreatic Resections
por: Mukhtar, Rita A., et al.
Publicado: (2008)

Incidence and Risk Factors for Implant Failure in Spinal Metastasis Surgery
por: Wong, Yu Chung, et al.
Publicado: (2020)

Pulmonary metastasectomy—is the extent of resection worth reconsidering?
por: Krüger, Marcus, et al.
Publicado: (2022)

The efforts are worth the benefits for laparoscopic liver resection
por: Willems, Edward, et al.
Publicado: (2023)

The Risk of Endoscopic Mucosal Resection in the Setting of Clopidogrel Use
por: Namasivayam, Vikneswaran, et al.
Publicado: (2014)

Adjuvant chemotherapy in elderly patients with pancreatic cancer
por: Nagrial, A M, et al.
Publicado: (2014)

Lymphatic, blood vessel and perineural invasion identifies early-stage high-risk radically resected gastric cancer patients
por: Scartozzi, M, et al.
Publicado: (2006)

Acute Renal Failure in Patients with Severe Falciparum Malaria: Using the WHO 2006 and RIFLE Criteria
por: Thanachartwet, Vipa, et al.
Publicado: (2013)

Renal Function in Patients with Hypertension Associated Congestive Cardiac Failure Seen in a Tertiary Hospital
por: Osuji, C. U., et al.
Publicado: (2012)

Pain Relieving Effect of Intraoperative Chemical Splanchnicectomy of Celiac Ganglions in Patients with Resectable Pancreatic or Gastric Masses: A Randomized Clinical Trial
por: Vahedian, Jalal, et al.
Publicado: (2020)

Assessing the benefit–risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer
por: Péron, J, et al.
Publicado: (2015)

Clinical outcomes of isolated renal failure compared to other forms of organ failure in patients with severe acute pancreatitis
por: Gougol, Amir, et al.
Publicado: (2017)

Association of Staphylococcus nasal colonization and HIV in end-stage renal failure patients undergoing peritoneal dialysis
por: Ndlovu, Kwazi C. Z., et al.
Publicado: (2019)

Is Losing Weight Worth Losing Your Kidney: Keto Diet Resulting in Renal Failure
por: Ayele, Girma M, et al.
Publicado: (2023)

Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma
por: Reni, Michele, et al.
Publicado: (2016)

Defining patient outcomes in stage IV colorectal cancer: a prospective study with baseline stratification according to disease resectability status
por: Watkins, D J, et al.
Publicado: (2010)

Pancreatic Stenting Reduces Post-ERCP Pancreatitis and Biliary Sepsis in High-Risk Patients: A Randomized, Controlled Study
por: Yin, He-Kun, et al.
Publicado: (2016)

Preoperative Nutritional Therapy Reduces the Risk of Anastomotic Leakage in Patients with Crohn's Disease Requiring Resections
por: Guo, Zhen, et al.
Publicado: (2016)

Multiple stents in pancreatic strictures of chronic pancreatitis: is it worth the effort?
por: Costamagna, Guido
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_atrbd7ufs16cgvf19r7glqm3rs